Explain Where Vraylar Fits Among Atypical Antipsychotics
July 2022
Vraylar (cariprazine) will be a new oral once-daily atypical antipsychotic...for schizophrenia or bipolar disorder.
Think of it as a cousin of Abilify (aripiprazole) or Rexulti (brexpiprazole)...they all partially act on dopamine D2 and various serotonin receptors.
Vraylar also partially acts on dopamine D3 receptors...which are thought to regulate cognition and mood. This may help reduce negative symptoms of schizophrenia (apathy, etc) or improve bipolar depression.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive